Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLS.L Regulatory News (SLS)

  • There is currently no data for SLS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison issues review on Standard Life UK Small.Co'

11 Dec 2018 15:40

RNS Number : 1540K
Standard Life UK Small.Co's Tst PLC
11 December 2018
 

 

London, UK, 11 December 2018

Edison issues review on Standard Life UK Smaller Companies (SLS)

Standard Life UK Smaller Companies (SLS) is managed by Harry Nimmo at Aberdeen Standard Investments. He has followed the same investment process since he took over management of the trust in 2003, through a number of economic cycles, and considers it to be stable, predictable and well defined, while providing an element of resilience during periods of stock market weakness. He also believes that the investment process is optimal for running large amounts of UK small-cap money. Nimmo has a long-term record of outperformance - SLS's NAV total return is ahead of its blended benchmark over the last one, three, five and 10 years, and above the averages of its larger peers in the AIC UK Smaller Companies sector over one and five years, and broadly in line over three years.

 

SLS's current 8.4% share price discount to cum-income NAV is wider than the 4.8% to 5.4% range of average discounts over the last one, three, five and 10 years. The board actively manages the discount, aiming to keep it below 8% (in normal market conditions - see page 7). This is achieved primarily via share repurchases. While the trust's objective is to generate long-term growth rather than income, SLS also offers a dividend yield of 1.7%.

Click here to view the full report.

 

All reports published by Edison are available to download free of charge from its website

www.edisoninvestmentresearch.com

About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information please contact Edison:

Mel Jenner, +44 (0)20 3077 5720

Gavin Wood, +44 (0)20 3681 2503

investmenttrusts@edisongroup.com

 

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-investment-research 

Twitter www.twitter.com/Edison_Inv_Res 

YouTube www.youtube.com/edisonitv 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRATBBATMBJBBMP
Date   Source Headline
7th Jan 20213:12 pmRNSMonth End Net Asset Value(s)
7th Jan 202111:26 amRNSNet Asset Value(s)
6th Jan 202112:20 pmRNSNet Asset Value(s)
5th Jan 20214:53 pmRNSQuarterly disclosure
5th Jan 202111:29 amRNSNet Asset Value(s)
4th Jan 20212:45 pmRNSGearing disclosure
4th Jan 202110:45 amRNSTotal Voting Rights
31st Dec 202012:36 pmRNSNet Asset Value(s)
30th Dec 202011:04 amRNSNet Asset Value(s)
29th Dec 20202:30 pmRNSGearing Disclosure
29th Dec 202012:08 pmRNSNet Asset Value(s)
24th Dec 202011:31 amRNSNet Asset Value(s)
23rd Dec 202011:47 amRNSNet Asset Value(s)
22nd Dec 202011:34 amRNSNet Asset Value(s)
21st Dec 20202:34 pmRNSGearing disclosure
21st Dec 202011:53 amRNSNet Asset Value(s)
18th Dec 202012:09 pmRNSNet Asset Value(s)
17th Dec 202012:12 pmRNSNet Asset Value(s)
16th Dec 202010:56 amRNSNet Asset Value(s)
15th Dec 20204:50 pmRNSTransaction in Own Shares
15th Dec 202011:14 amRNSNet Asset Value(s)
14th Dec 20203:46 pmRNSGearing disclosure
14th Dec 202012:20 pmRNSNet Asset Value(s)
14th Dec 202011:10 amRNSPortfolio disclosure
11th Dec 202012:34 pmRNSNet Asset Value(s)
10th Dec 202012:30 pmRNSNet Asset Value(s)
9th Dec 202011:06 amRNSNet Asset Value(s)
8th Dec 202011:49 amRNSNet Asset Value(s)
7th Dec 202012:09 pmRNSGearing Disclosure
7th Dec 202011:09 amRNSNet Asset Value(s)
4th Dec 20202:31 pmRNSMonth End Net Asset Value(s)
4th Dec 202011:13 amRNSNet Asset Value(s)
3rd Dec 202012:39 pmRNSNet Asset Value(s)
2nd Dec 20201:16 pmRNSNet Asset Value(s)
1st Dec 202010:02 amRNSTotal Voting Rights
30th Nov 20202:58 pmRNSGearing disclosure
30th Nov 202011:54 amRNSNet Asset Value(s)
27th Nov 202012:47 pmRNSNet Asset Value(s)
26th Nov 202012:22 pmRNSNet Asset Value(s)
25th Nov 202012:52 pmRNSNet Asset Value(s)
24th Nov 202012:42 pmRNSNet Asset Value(s)
23rd Nov 20202:40 pmRNSEdison issues review on Standard Life UK Smaller
23rd Nov 20201:23 pmRNSGearing disclosure
23rd Nov 202012:50 pmRNSNet Asset Value(s)
20th Nov 20205:09 pmRNSTransaction in Own Shares
20th Nov 202011:05 amRNSNet Asset Value(s)
19th Nov 20205:11 pmRNSTransaction in Own Shares
19th Nov 202011:04 amRNSNet Asset Value(s)
18th Nov 20205:15 pmRNSTransaction in Own Shares
18th Nov 20201:25 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.